Trial
NCT00953459
Sunitinib Malate in Treating Patients With Small Cell Lung Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
—
Condition
Lung Cancer
Intervention
sunitinib malate
Why stopped
poorly recruiting
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-26